France Gives Medical Cannabis A Tentative ‘Oui’
The first medical marijuana conference in Bordeaux, France, featuring doctors, scientists, and entrepreneurs from the UK and ...
Knowridge14h
Scientists discover big cause of multiple sclerosis
Multiple sclerosis (MS) is a progressive autoimmune disease that affects the brain and spinal cord, impacting 2.8 million ...
People on PIP, ADP and other disability benefits can access exclusive online discounts off top brands
More than 25,000 people have signed up to Purpl since it launched last July, giving them access to discounts with hundreds of ...
biopharma-reporter13h
Roche’s Elevidys demonstrates significant benefits for DMD patients in Phase 3
The gene therapy improved motor functions in children with Duchenne muscular dystrophy two years after treatment ...
Floridians living with multiple sclerosis find hope in new treatments
Susie Wyss used to inject herself daily with a medication for multiple sclerosis. “The injection hurt. It caused welts, bruises, and sometimes permanent lipoatrophy,” Wyss told more than 800 people ...
Novartis to Report Q4 Earnings: What's in the Offing?
NVS' key drugs, Entresto, Cosentyx Kisqali and Pluvicto, are likely to have fueled its top and bottom-line performance in the ...
Biologics Market Research Report 2024-2030: Technological Innovations in Monoclonal Antibodies and Gene Therapies Fueling Developments and Growth
The "Biologics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global ...
Landmark Cleveland Clinic brain study seeks diversity in quest to unlock neurological mysteries
The Clinic's study has already enrolled 3,600 participants, but the goal is a diverse group of 200,000. Right now, more men ...
The 7 symptoms of ‘silent vision killer’ after Alan Carr suffers terrifying health scare
ALAN CARR has revealed he’s “losing his sight” and needs to get a “worrying” hospital procedure. The 48-year-old Chatty Man ...